Yuanyuan Kong

26PUBLICATIONS
39CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical biochemistry - lipidsPacific Peoples diet and nutritionMetabolic medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Jul 03, 2026
Beyond side effects: treatment-related adverse events are associated with improved survival outcomes in HCC patients on atezolizumab-bevacizumab therapy.

|Mar 14, 2026
Clinical Trials for Curing Chronic Hepatitis B: A Comprehensive Analysis of Trial Design Considerations and Their Association With Trial Performance.

Lichen Shi, Hao Wang, Cheng Huang

|Nov 14, 2025
Serial Liver Stiffness Measurement and Serum Biomarkers Are Not Strong Predictors of the Regression of Fibrosis among Chronic Hepatitis B Patients Receiving Antiviral Therapy Based on Triple Liver Biopsies.

Jiayi Zhang, Shuyan Chen, Jialing Zhou

|Sep 23, 2025
Stage-Specific Transcriptome Landscape of Hepatocellular Carcinoma: Insights From Super and Poor Survivors With Prognostic Signature Identification.

Xiao Qian Xu, Hao Wang, Li Chen Shi

|Sep 02, 2025
Impact of temporary atezolizumab and bevacizumab interruption on survival in advanced HCC: an IMbrave150 analysis.

Xiao-Qian Xu, Wei-Ming Li, Li-Chen Shi

|Aug 01, 2025
GLOBE Score and UK-PBC Risk Score Predict Long-Term Clinical Outcomes of Patients With Primary Biliary Cholangitis and Receiving Ursodeoxycholic Acid and Fenofibrate.

Shu Xiang Li, Bu Er Li, Min Li

Pageof 5

Frequent Collaborators

13 joint publications

Jidong Jia

8 joint publications

Hong You

4 joint publications

Min Li

3 joint publications

Zhongtao Zhang